KatherineWesseling(Wesseling)PerryMDMSCR

PubMed

• 9 citations
  Gut microbiome, parathyroid hormone, and bone.
  Elizabeth Kermgard, Nadine Khouzam Chawla, Katherine Wesseling-Perry> ;Current Opinion in Nephrology and Hypertension. 2021 Jul 1
• Bone marrow adiposity inversely correlates with bone turnover in pediatric renal osteodystrophy.
  Ornatcha Sirimongkolchaiyakul, Renata C. Pereira, Barbara Gales, Justine Bacchetta, Isidro B. Salusky, Katherine Wesseling-Perry> ;Bone Reports. 2021 Jul 8
• 3 citations
  Associations among erythropoietic, iron-related, and FGF23 parameters in pediatric kidney transplant recipients
  Blair Limm-Chan, Katherine Wesseling-Perry, Meghan H. Pearl, Grace Jung, Eileen Tsai-Chambers, Patricia L. Weng, Mark R. Hanudel> ;Pediatric Nephrology. 2021 Apr 26
• 12 citations
  Bone material properties and response to teriparatide in osteoporosis due to WNT1 and PLS3 mutations
  Nadja Fratzl-Zelman, Katherine Wesseling-Perry, Riikka E. Mäkitie, Stéphane Blouin, Markus Hartmann, Jochen Zwerina, Ville-Valtteri Välimäki, Christine M. Laine, Matti...> ;Bone. 2021 May 1
• DYRK1A pathogenic variants in two patients with syndromic intellectual disability and a review of the literature.
  Meissner LE, Macnamara EF, D'Souza P, Yang J, Vezina G, Undiagnosed Diseases Network, Ferreira CR, Zein WM, Tifft CJ, Adams DR> ;Molecular genetics & genomic medicine. 2020-11-07
• 5 citations
  Vitamin C overload may contribute to systemic oxalosis in children receiving dialysis
  Sabina S Kennedy, Ashley Perilloux, Renata C. Pereira, Garry J. Handelman, Katherine Wesseling-Perry, Isidro B. Salusky> ;Pediatric Nephrology. 2021 Feb 1
• 5 citations
  Nephropathic Cystinosis: A Distinct Form of CKD-Mineral and Bone Disorder that Provides Novel Insights into the Regulation of FGF23.
  Pablo Florenzano, Macarena Jiménez, Carlos Ferreira, Galina Nesterova, Mary Scott Roberts, Sri Harsha Tella, Luis F de Castro, Rachel I Gafni, Myles Wolf, Harald Jüppn...> ;Journal of the American Society of Nephrology. 2020 Jul 6
• 22 citations
  Use of Denosumab in Children With Osteoclast Bone Dysplasias: Report of Three Cases.
  Alexander Upfill-Brown, Susan V. Bukata, Nicholas M. Bernthal, Alan L Felsenfeld, Scott D. Nelson, Arun S. Singh, Katherine Wesseling-Perry, Fritz C. Eilber, Noah Fede...> ;JBMR Plus. 2019 Aug 22
• 67 citations
  The consequences of chronic kidney disease on bone metabolism and growth in children
  Justine Bacchetta, Jérôme Harambat, Pierre Cochat, Isidro B. Salusky, Katherine Wesseling-Perry> ;Nephrology, Dialysis, Transplantation. 2012 Aug 1
• The Authors Reply.
  Katherine Wesseling-Perry> ;Kidney International. 2015 Sep 1
• 9 citations
  Defective skeletal mineralization in pediatric CKD.
  Katherine Wesseling-Perry> ;Current Osteoporosis Reports. 2015 Feb 1
• 19 citations
  Vitamin D sterols increase FGF23 expression by stimulating osteoblast and osteocyte maturation in CKD bone.
  Renata C. Pereira, Isidro B. Salusky, Richard E. Bowen, Earl Freymiller, Katherine Wesseling-Perry> ;Bone. 2019 Aug 1
• 16 citations
  Impaired osteocyte maturation in the pathogenesis of renal osteodystrophy
  Renata C. Pereira, Isidro B. Salusky, Paul Roschger, Klaus Klaushofer, Ora Yadin, Earl Freymiller, Richard E. Bowen, Anne M. Delany, Nadja Fratzl-Zelman, Katherine Wes...> ;Kidney International. 2018 Nov 1
• 3 citations
  Osteocyte dysfunction and renal osteodystrophy: not just calcium and phosphorus anymore
  Katherine Wesseling-Perry> ;Kidney International. 2017 Jun 1
• 20 citations
  Osteocyte Protein Expression Is Altered in Low-Turnover Osteoporosis Caused by Mutations in WNT1 and PLS3.
  Katherine Wesseling-Perry, Riikka E. Mäkitie, Ville-Valtteri Välimäki, Tero Laine, Christine M. Laine, Matti Välimäki, Renata C. Pereira, Outi Mäkitie> ;The Journal of Clinical Endocrinology and Metabolism. 2017 Jul 1
• 23 citations
  Teriparatide Treatment in Patients With WNT1 or PLS3 Mutation-Related Early-Onset Osteoporosis: A Pilot Study.
  Ville-Valtteri Välimäki, Outi Mäkitie, Renata C. Pereira, Christine M. Laine, Katherine Wesseling-Perry, Jorma A. Määttä, Mikko O. Kirjavainen, Heli Viljakainen, Matti...> ;The Journal of Clinical Endocrinology and Metabolism. 2016 Oct 12
• 76 citations
  Kidney-on-a-chip: untapped opportunities.
  Nureddin Ashammakhi, Katherine Wesseling-Perry, Anwarul Hasan, Elmahdi A. Elkhammas, Yu Shrike Zhang> ;Kidney International. 2018 Dec 1
• 1 citations
  Erratum to "Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease" [Bone, 45(6) (2009) 1161-1168].
  Renata C. Pereira, Harald Jűppner, Carlos E. Azucena-Serrano, Ora Yadin, Isidro B. Salusky, Katherine Wesseling-Perry> ;Bone. 2017 Dec 1
• 10 citations
  Pathophysiology and treatment of cardiovascular disease in pediatric chronic kidney disease
  Nadine Khouzam, Katherine Wesseling-Perry> ;Pediatric Nephrology. 2019 Jan 1
• 8 citations
  Efficacy and safety of sevelamer carbonate in hyperphosphatemic pediatric patients with chronic kidney disease
  Sahar Fathallah-Shaykh, Dorota Drozdz, Joseph T. Flynn, Randall Jenkins, Katherine Wesseling-Perry, Sarah J. Swartz, Craig S. Wong, Beverly Accomando, Gerald F. Cox, B...> ;Pediatric Nephrology. 2018 Feb 1
• 6 citations
  Abnormally High and Heterogeneous Bone Matrix Mineralization After Childhood Solid Organ Transplantation: A Complex Pathology of Low Bone Turnover and Local Defects in...
  Nadja Fratzl-Zelman, Helena Valta, Renata C. Pereira, Barbara M. Misof, Paul Roschger, Hannu Jalanko, Katherine Wesseling-Perry, Klaus Klaushofer, Outi Mäkitie> ;Journal of Bone and Mineral Research. 2017 May 1
• 1 citations
  Correction: Bone Canopies in Pediatric Renal Osteodystrophy.
  Renata C. Pereira, Thomas Levin Andersen, Peter A. Friedman, Navdeep Tumber, Isidro B. Salusky, Katherine Wesseling-Perry> ;Plos One. 2016 May 11
• 5 citations
  Bone Canopies in Pediatric Renal Osteodystrophy
  Renata C. Pereira, Thomas Levin Andersen, Peter A. Friedman, Navdeep Tumber, Isidro B. Salusky, Katherine Wesseling-Perry> ;Plos One. 2016 Apr 5
• 20 citations
  Micro-CT in the Assessment of Pediatric Renal Osteodystrophy by Bone Histomorphometry
  Renata C. Pereira, David S. Bischoff, Dean T. Yamaguchi, Isidro B. Salusky, Katherine Wesseling-Perry> ;Clinical Journal of the American Society of Nephrology. 2016 Mar 7
• 25 citations
  Effects of acute kidney injury and chronic hypoxemia on fibroblast growth factor 23 levels in pediatric cardiac surgery patients
  Mark R. Hanudel, Katherine Wesseling-Perry, Barbara Gales, Georgina Ramos, Vicky Campbell, Kristen Ethridge, Mary Scotti, David Elashoff, Juan C. Alejos, Brian Reemtse...> ;Pediatric Nephrology. 2016 Jan 1
• Join now to see all

Journal Articles

• FGF23 inhibits extra-renal synthesis of 1,25-diydroxyvitamin D in human monocytes  
  Bacchetta J, Sea JL, Chun RF, Lisse TS, Wesseling-Perry K, Gales B, Adams JS, Salusky IB, Hewison M, J Bone Miner Res, 1/1/2013
• Idiopathic juvenile osteoporosis: a cross-sectional single-centre experience with bone histomorphometry and quantitative computed tomography  
  Bacchetta J, Wesseling-Perry K, Gilsanz V, Gales B, Pereira RC, Salusky IB, Pediatr Rheumatol Online J, 1/1/2013
• The skeletal consequences of growth hormone therapy in dialyzed children: a randomized trial  
  Bacchetta J, Wesseling-Perry K , Kuizon B, Pereira RC, Gales B, Wang H, Elashoff R, Salusky IB, Clinical Journal of the American Society of Nephrology, 1/1/2013
• FGF23 and mineral metabolism in the early post-renal transplantation period  
  Wesseling-Perry K, Pereira RC, Tsai E, Ettenger R, Juppner H, Salusky IB, Pediatr Neprhol, 1/1/2013
• Short daily hemodialysis is associated with lower plasma FGF23 levels when compared with conventional hemodialysis  
  Zaritsky J, Rastogi A, Fischmann G, Yan J, Kleinman K, Chow G, Gales B, Salusky IB, Wesseling-Perry K, Nephrol Dial Transplant, 1/1/2013
• Bone biopsy in renal osteodystrophy: continued insights into a complex disease  
  Christov M, Pereira R, Wesseling-Perry K, Curr Opin Nephrol Hypertens, 1/1/2013
• Phosphate binders, vitamin D and calcimimetics in the management of chronic kidney disease-mineral bone disorders (CKD-MBD) in children  
  Wesseling-Perry K, Salusky IB, Pediatr Nephrol, 1/1/2013
• Chronic kidney disease: mineral and bone disorder in children  
  Wesseling-Perry K and Salusky IB, Semin Nephrol, 1/1/2013
• Early Skeletal and Biochemical Alterations in Pediatric Chronic Kidney Disease  
  Wesseling-Perry K, Pereira RC, Tseng CH, Elashoff R, Zaritsky JJ, Yadin O, Sahney S, Gales B, Juppner H, Salusky IB, Clinical Journal of the American Society of Nephrology, 1/1/2012
• Uric acid and IGF1 as potential determinants of FGF23 metabolism in children with normal renal function  
  Bacchetta J, Cochat P, Salusky IB, Wesseling-Perry K, Pediatric Nephrology, 1/1/2012
• The consequences of chronic kidney disease on bone metabolism and growth in children  
  Bacchetta J, Harambat J, Cochat P, Salusky IB, Wesseling-Perry K, Nephrol Dial Transplant, 1/1/2012
• Bone disease in pediatric chronic kidney disease  
  Wesseling-Perry K, Pediatric Nephrology, 1/1/2012
• The osteocyte in CKD: new concepts regarding the role of FGF23 in mineral metabolism and systemic complications  
  Wesseling-Perry K and Juppner H, Bone, 1/1/2012
• Calcitriol and Doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hy...  
  Wesseling-Perry K, Pereira RC, Sahney S, Gales B, Wang H, Elashoff R, Juppner H, and Salusky IB, Kidney International, 1/1/2011
• Racial differences in correlations between reported dietary intakes of carotenoids and their concentration biomarkers  
  Arab L, Cambou MC, Craft N, Wesseling-Perry K, Jardack P, Ang A, American Journal of Clinical Nutrition, 1/1/2011
• Mineral abnormalities and long-term graft function in pediatric renal transplant recipients: a role for FGF-23?  
  Wesseling-Perry K, Tsai EW, Ettenger RB, Juppner H, and Salusky IB, Nephrology, Dialysis, Transplantation, 1/1/2011
• CKD-MBD after kidney transplantation  
  Wesseling-Perry K, Bacchetta J, Pediatric Nephrology, 1/1/2011
• FGF-23: Is It Ready for Prime-Time?  
  Wesseling-Perry K, Clin Chem, 1/1/2011
• Value of the New Bone Classification System in Pediatric Renal Osteodystrophy  
  Bakkaloglu S, Wesseling-Perry K, Pereira R, Gales B, Wang H, Elashoff R, and Salusky IB, Clinical Journal of the American Society of Nephrology, 10/5/2010
• The calcemic response to continuous PTH infusion in end-stage kidney disease varies according to bone turnover: a potential role for PTH(7-84)  
  Wesseling-Perry K, Harkins GC, Wang H, Elashoff R, Gales B, Horwitz MJ, Stewart AF, Juppner H, and Salusky IB, Journal of Clinical Endocrinology and Metabolism, 6/1/2010
• Eight self-administered 24-hour dietary recalls using the internet are feasible in African-Americans and Whites: the energetics study  
  Arab L, Wesseling-Perry K, Jardack P, Henry J, Winter A, Journal of the American Dietetic Association, 6/1/2010
• Circulating fibroblast growth factor 23 in patients with end-stage renal disease by peritoneal dialysis is intact and biologically active  
  Shimada T, Urakawa I, Isakova T, Yamazaki Y, Epstein M, Wesseling-Perry K, Wolf M, Salusky IB, and Juppner H, Journal of Clinical Endocrinology and Metabolism, 2/1/2010
• FGF-23 in Bone Biology  
  Wesseling-Perry K, Pediatric Nephrology, 1/1/2010
• Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease  
  Pereira RC, Juppner H, Yadin O, Salusky IB, and Wesseling-Perry K, Bone, 12/1/2009
• Is replacement therapy with nutritional and active forms of vitamin D required in Chronic Kidney Disease Mineral and Bone Disorder?  
  Wesseling-Perry K and Salusky IB, Current Opinion in Nephrology and Hypertension, 7/1/2009
• Join now to see all